CD4 and T-cell non-Hodgkin lymphoma: Pinz et al. used anti-CD4 CAR-T cells to eliminate CD4+ T cell lymphomas (TCLs) or T cell acute lymphoblastic leukemia (T-ALL), demonstrating that almost all CD4+ CAR-T cells were also depleted.